Related Experiment Video

Updated: Jul 17, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

134.6K

Update on antineutrophil cytoplasmic autoantibody vasculitis in children

Jessica L Bloom1, Eveline Y Wu2,3

  • 1University of Colorado, Department of Pediatrics, Division of Rheumatology, Denver, Colorado.

Current Opinion in Rheumatology
|July 11, 2024
PubMed

Insights

Recent research advances understanding of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) in children. Further studies and funding are crucial for improved diagnosis, treatment, and outcomes in pediatric AAV.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Clinical Research

Background:

  • Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) poses significant risks to children's organ function and development.
  • Pediatric AAV impacts critical psychosocial and physical developmental stages.
  • Current understanding of AAV in children requires further investigation.

Purpose of the Study:

  • To review recent advancements in the pathophysiology of pediatric AAV.
  • To summarize current diagnostic and management strategies for AAV in children.
  • To highlight outcomes and identify needs for future research, funding, and collaboration in pediatric AAV.

Main Methods:

  • Review of recent scientific literature on pediatric AAV.
  • Analysis of collaborative clinical studies focusing on pediatric manifestations and outcomes.
  • Evaluation of emerging consensus-based treatment guidelines.

Main Results:

  • Improved understanding of AAV pathogenesis, with potential for new biomarkers and therapeutic targets.
  • Identification of variable clinical manifestations and factors associated with poorer outcomes in pediatric AAV.
  • Development of consensus treatment guidelines, underscoring the need for pediatric-specific clinical trials.

Conclusions:

  • Significant progress has been made in pediatric AAV research, fostering optimism for the future.
  • There is an ongoing and critical need for more rigorous scientific investigation in pediatric AAV.
  • Development of validated, patient-reported outcome measures is essential for advancing clinical trials in pediatric AAV.
Abstract

More Related Videos

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood07:20

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

Published on: January 9, 2018

9.9K
Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

6.9K

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...